Biotech companies
Therapeutics, drug discovery and life-science platforms, ranked by how many investors have backed each one.
Most backed biotech companies
Ranked by the number of distinct investors on record. Investor counts come from recorded rounds, so a company with few investors may simply be early rather than unbacked.
Nuritas
series bTubulis
series bAgomab Therapeutics
series bDayTwo
series c plusMemo Therapeutics AG
acquiredNuclera
series bChromologics
series aClean Food Group
series aGenSight
series c plusOnego Bio
series aRecursion
series c plusTurbine
series aakouos
acquiredAscend
series c plusAvalyn Pharma
series c plusBiorce
seedCUTISS
series bDNA Script
series c plusEnterome
series c plusGenomics
series aGrail
series c plusHealx
series bMOA Foodtech
seedMolecule
series bNaturbeads
series aOwkin
series c plusPromethera Biosciences
series c plusSeqOne
series bTailor Bio Ltd
seedTissium
series c plusAgrobiomics
series c plusAlithea Genomics
series aAltos Labs
series c plusAntiverse
series aAphea.Bio
series bAzafaros
series bC4 Therapeutics
series c plusCradle
series aElevateBio
series c plusF2G
series bGreen City Solutions
series aHemotune
series bHilleVax
series bIsomorphic Labs
series c plusLabGenius
series bMiAlgae
series c plusMicropep
series bQkine
series aSlingshot Biosciences
series aSynthace
series c plusTagomics
series aVir Biotechnology
series aABclonal
series c plusAbcuro
series c plusAmolyt Pharma
acquiredAnocca
series bantiva biosciences
series c plusBenchling
series c plusBillionToOne
series aBioAge Labs
series c plusWhere biotech companies are, and how far along
Computed across the whole tagged set, not just the companies listed above. Percentages are of the companies that have the field recorded, which is stated for each.
By country
1,964 companies with a recorded country
- United States71837%
- United Kingdom28314%
- Germany1578%
- France1387%
- Switzerland794%
- Netherlands774%
- Sweden714%
- China513%
By stage
1,546 companies with a recorded stage
- Series A42527%
- Seed42427%
- Series C+29819%
- Series B26017%
- Pre seed654%
- Acquired624%
- Pre-IPO50%
- Growth20%
Who funds biotech
The investors behind these companies are ranked on the biotech investor page, ordered by how many biotech companies each one has actually funded rather than by stated focus.